1281O Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB+) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C

Rafał Dziadziuszko, Solange Peters, Shirish M. Gadgeel, Mariann Mathisen, Sarah M. Shagan, Enriqueta Felip, Alessandro Morabito, Parneet Cheema, Manuel Cobo, Z. Andric, C.H. Barrios, Masafumi Yamaguchi, Éric Dansin, Pongwut Danchaivijitr, Melissa L. Johnson, Silvia Novello, David R. Gandara, Erica Schleifman, J. Wang, Tony Mok